BTK 抗体

Yu, Bondada, Ghoshal, Singh, Pistilli, Dayaram, Iqbal, Sands, Davis, Bondada, Geddes: "Repositioning Flubendazole for Spinal Cord Injury." in: Journal of neurotrauma, (2019) (PubMed).

Liu, Zhang, Han, Wang, Liu, Zhang, Zhou, Xiang: "Inhibition of BTK protects lungs from trauma-hemorrhagic shock-induced injury in rats." in: Molecular medicine reports, Vol. 16, Issue 1, pp. 192-200, (2017) (PubMed).

Hoshino, Okuno, Migita, Ban, Yang, Kiyokawa, Adachi, Kojima, Ohara, Kanegane: "X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia." in: Journal of clinical immunology, Vol. 35, Issue 2, pp. 108-11, (2015) (PubMed).

Wang, Iwata, Nakayamada, Niiro, Jabbarzadeh-Tabrizi, Kondo, Kubo, Yoshikawa, Tanaka: "Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation." in: Rheumatology (Oxford, England), Vol. 54, Issue 8, pp. 1488-97, (2015) (PubMed).

Eda, Santo, Cirstea, Yee, Scullen, Nemani, Mishima, Waterman, Arastu-Kapur, Evans, Singh, Kirk, Westlin, Raje et al.: "A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma ..." in: Leukemia, Vol. 28, Issue 9, pp. 1892-901, (2014) (PubMed).

Gleixner, Peter, Blatt, Suppan, Reiter, Radia, Hadzijusufovic, Valent: "Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V." in: Haematologica, Vol. 98, Issue 9, pp. 1450-7, (2013) (PubMed).

Lindvall, Blomberg, Väliaho, Vargas, Heinonen, Berglöf, Mohamed, Nore, Vihinen, Smith: "Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling." in: Immunological reviews, Vol. 203, pp. 200-15, (2005) (PubMed).

Akira, Takeda: "Toll-like receptor signalling." in: Nature reviews. Immunology, Vol. 4, Issue 7, pp. 499-511, (2004) (PubMed).

Jefferies, ONeill: "Bruton's tyrosine kinase (Btk)-the critical tyrosine kinase in LPS signalling?" in: Immunology letters, Vol. 92, Issue 1-2, pp. 15-22, (2004) (PubMed).

Jefferies, Doyle, Brunner, Dunne, Brint, Wietek, Walch, Wirth, ONeill: "Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4." in: The Journal of biological chemistry, Vol. 278, Issue 28, pp. 26258-64, (2003) (PubMed).